Brief Report: Active HIV Case Finding in the City of Kigali, Rwanda: Assessment of Voluntary Assisted Partner Notification Modalities to Detect Undiagnosed HIV Infections.
Journal
Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
received:
09
07
2021
accepted:
15
11
2021
entrez:
24
2
2022
pubmed:
25
2
2022
medline:
9
3
2022
Statut:
ppublish
Résumé
Voluntary assisted partner notification (VAPN) services that use contract, provider, or dual referral modalities may be efficient to identify individuals with undiagnosed HIV infection. We aimed to assess the relative effectiveness of VAPN modalities in identifying undiagnosed HIV infections. VAPN was piloted in 23 health facilities in Kigali, Rwanda. We identified individuals with a new HIV diagnosis before antiretroviral therapy initiation or individuals on antiretroviral therapy (index cases), who reported having had sexual partners with unknown HIV status, to assess the association between referral modalities and the odds of identifying HIV-positive partners using a Bayesian hierarchical logistic regression model. We adjusted our model for important factors identified through a Bayesian variable selection. Between October 2018 and December 2019, 6336 index cases were recruited, leading to the testing of 7690 partners. HIV positivity rate was 7.1% (546/7690). We found no association between the different referral modalities and the odds of identifying HIV-positive partners. Notified partners of male individuals (adjusted odds ratio 1.84; 95% credible interval: 1.50 to 2.28) and index cases with a new HIV diagnosis (adjusted odds ratio 1.82; 95% credible interval: 1.45 to 2.30) were more likely to be infected with HIV. All 3 VAPN modalities were comparable in identifying partners with HIV. Male individuals and newly diagnosed index cases were more likely to have partners with HIV. HIV-positive yield from index testing was higher than the national average and should be scaled up to reach the first UNAIDS-95 target by 2030.
Sections du résumé
BACKGROUND
Voluntary assisted partner notification (VAPN) services that use contract, provider, or dual referral modalities may be efficient to identify individuals with undiagnosed HIV infection. We aimed to assess the relative effectiveness of VAPN modalities in identifying undiagnosed HIV infections.
SETTING
VAPN was piloted in 23 health facilities in Kigali, Rwanda.
METHODS
We identified individuals with a new HIV diagnosis before antiretroviral therapy initiation or individuals on antiretroviral therapy (index cases), who reported having had sexual partners with unknown HIV status, to assess the association between referral modalities and the odds of identifying HIV-positive partners using a Bayesian hierarchical logistic regression model. We adjusted our model for important factors identified through a Bayesian variable selection.
RESULTS
Between October 2018 and December 2019, 6336 index cases were recruited, leading to the testing of 7690 partners. HIV positivity rate was 7.1% (546/7690). We found no association between the different referral modalities and the odds of identifying HIV-positive partners. Notified partners of male individuals (adjusted odds ratio 1.84; 95% credible interval: 1.50 to 2.28) and index cases with a new HIV diagnosis (adjusted odds ratio 1.82; 95% credible interval: 1.45 to 2.30) were more likely to be infected with HIV.
CONCLUSION
All 3 VAPN modalities were comparable in identifying partners with HIV. Male individuals and newly diagnosed index cases were more likely to have partners with HIV. HIV-positive yield from index testing was higher than the national average and should be scaled up to reach the first UNAIDS-95 target by 2030.
Identifiants
pubmed: 35202049
doi: 10.1097/QAI.0000000000002878
pii: 00126334-202204010-00009
pmc: PMC8860213
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
423-427Informations de copyright
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Institut National de la Statistique du Rwanda (INSR) and ORC Macro. Rwanda Demographic and Health Survey 2005. Calverton, MD: INSR and ORC Macro; 2006.
National Institute of Statistics of Rwanda (NISR) [Rwanda], Ministry of Health (MOH) [Rwanda], and ICF International. Rwanda Demographic and Health Survey 2010. Calverton, MD: NISR, MOH, and ICF International; 2011.
National Institute of Statistics of Rwanda (NISR) [Rwanda], Ministry of Health (Rwanda), ICF International (Rockville, MD): Rwanda Demographic and Health Survey 2014–15. Rockville, MD: NISR, MOH, and ICF International.
Rwanda Biomedical Centre (RBC), National Institute of Statistics of Rwanda (NISR), The United States President's Emergency Plan for AIDS Relief (PEPFAR), The United States Centers for Disease Control and Prevention (CDC), Westat, ICAP at Columbia University. Rwanda Population-Based HIV Impact Assessment (RPHIA) 2018–2019: Final Report. 2020. Available at: https://phia.icap.columbia.edu/wp-content/uploads/2020/11/RPHIA-Final-Report_web.pdf . Accessed December 30, 2020.
Ministry of Health (Rwanda), International Center for AIDS Care and Treatment Programs (ICAP). Rwanda Population Based HIV Impact Assessment. 2019. Available at: https://phia.icap.columbia.edu/wp-content/uploads/2019/10/RPHIA-Summary-Sheet_Oct-2019.pdf . Accessed May 17, 2021.
Rwanda Biomedical Centre. National HIV and Viral Hepatitis Annual Report 2019–2020. Kigali, Rwanda: Rwanda Biomedical Centre; 2020. Available at https://www.rbc.gov.rw/fileadmin/user_upload/report2019/53059%20RPHIA_Report_V9_Web.pdf .
World Health Organization (WHO). Guidelines on HIV self-testing and partner notification. Supplement to consolidated guidelines on HIV testing services. 2016. Available at: http://apps.who.int/iris/bitstream/handle/10665/251655/9789241549868-eng.pdf;jsessionid=6D620F3520A65BEBAB09CB2D6CFFBA24?sequence=1 . Accessed May 19, 2021.
Rwanda Ministry of Health. Rwanda Biomedical Centre. National HIV and Viral Hepatitis Annual Report 2017–2018. Kigali- Rwanda; 2018.
Rwanda Biomedical Centre. National Guidelines for Prevention and Management of HIV and STIs. Kigali- Rwanda; 2017.
Dellaportas P, Forster JJ, Ntzoufras I. On Bayesian model and variable selection using MCMC. Stat Comput. 2002;12:27–36.
Buhikire K, Voss J, Kigozi J, et al. Reaching the first 90 in Uganda: predictors of success in contacting and testing the named sexual partners of HIV+ index clients in Kiboga District. AIDS Behav. 2018;22:2458–2467.
Kahabuka C, Plotkin M, Christensen A, et al. Addressing the first 90: a highly effective partner notification approach reaches previously undiagnosed sexual partners in Tanzania. AIDS Behav. 2017;21:2551–2560.
Joseph Davey D, Wall KM, Serrao C, et al. HIV positivity and referral to treatment following testing of partners and children of PLHIV index patients in public sector facilities in South Africa. J Acquir Immune Defic Syndr. 2019;81:365–370.
Masyuko SJ, Cherutich PK, Contesse MG, et al. Index participant characteristics and HIV assisted partner services efficacy in Kenya: results of a cluster randomized trial. J Int AIDS Soc. 2019;22(suppl 3):e25305.
Mahachi N, Muchedzi A, Tafuma TA, et al. Sustained high case‐finding through index testing and partner notification services: experiences from three provinces in Zimbabwe. J Int AIDS Soc. 2019;22(suppl 3):e25321.
Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV. BMJ. 1992;304:809–813.
Padian NS. Female-to-male transmission of human immunodeficiency virus. JAMA. 1991;266:1664.
Plotkin M, Kahabuka C, Christensen A, et al. Outcomes and experiences of men and women with partner notification for HIV testing in Tanzania: results from a mixed method study. AIDS Behav. 2018;22:102–116.
Obermeyer CM, Osborn M. The utilization of testing and counseling for HIV: a review of the social and behavioral evidence. Am J Public Health. 2007;97:1762–1774.
Maman S, Medley A; World Health Organization, Department of Gender and Women's Health. Gender Dimensions of HIV Status Disclosure to Sexual Partners: Rates, Barriers, and Outcomes: A Review Paper. Geneva, Switzerland: Dept. of Gender and Women’s Health (GWH), Family and Community Health (FCH), World Health Organization; 2003.
UNAIDS. Blind Spot—Reaching Out to Men and Boys Addressing a Blind Spot in the Response to HIV. Geneva, Switzerland: UNAIDS; 2017. Available at: https://www.unaids.org/sites/default/files/media_asset/blind_spot_en.pdf . Accessed May 17, 2021.
DiCarlo AL, Mantell JE, Remien RH, et al. ‘Men usually say that HIV testing is for women’: gender dynamics and perceptions of HIV testing in Lesotho. Cult Health Sex. 2014;16:867–882.
Skovdal M, Campbell C, Madanhire C, et al. Masculinity as a barrier to men's use of HIV services in Zimbabwe. Glob Health. 2011;7:13.
Siu GE, Wight D, Seeley JA. Masculinity, social context and HIV testing: an ethnographic study of men in Busia district, rural eastern Uganda. BMC Public Health. 2014;14:33.
Ross J, Sinayobye d'Amour J, Yotebieng M, et al. Early outcomes after implementation of treat all in Rwanda: an interrupted time series study. J Int AIDS Soc. 2019;22:e25279.